Antifungal Agents

3 researchers across 1 institution

3 Researchers
1 Institutions
0 Grant PIs
2 High Impact

Research in antifungal agents focuses on identifying, developing, and understanding compounds that combat fungal infections. This work involves synthesizing novel chemical structures, screening existing libraries for activity against pathogenic fungi, and investigating the mechanisms by which these agents kill or inhibit fungal growth. Studies examine drug resistance, explore natural product sources for antifungal compounds, and assess the efficacy and safety of potential treatments in laboratory models. Key areas include the development of new therapies for invasive fungal diseases, particularly in vulnerable patient populations.

This research is relevant to Arkansas through its potential impact on public health, especially concerning agricultural workers and individuals with compromised immune systems who are susceptible to fungal pathogens. Fungal diseases can affect crop yields and livestock, impacting the state's significant agricultural economy. Furthermore, understanding and treating fungal infections is crucial for healthcare providers across Arkansas, addressing a persistent challenge in clinical settings.

This field draws upon expertise in medicinal chemistry, microbiology, pharmacology, and public health. Collaboration extends across institutions to leverage diverse skills and resources, contributing to a comprehensive approach to antifungal drug discovery and development.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
William J. Steinbach UAMS 68 26,374 High Impact
Robert W. Bradsher UAMS 36 8,962 High Impact
Juan Carlos Rico UAMS 7 245

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
6,327 works in 2025
+2.3% CAGR 2018–2025
Leadership concentration
3.5% held by global top 5 institutions
Fragmented HHI 13
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 Duke Medical Center 1,021
  2. 2 The University of Texas MD Anderson Cancer Center 902
  3. 3 Centers for Disease Control and Prevention 899
  4. 4 Duke University 887
  5. 5 The University of Texas at San Antonio Health Science Center 869
Browse All 3 Researchers in Directory